~~<i id='0D755A112F'><strike id='0D755A112F'><tt id='0D755A112F'><pre id='0D755A112F'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

author：Wikipedia 2025-10-01 11:09:50 Page View：7

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： WATCH: Why do fingernails fall off when they're damaged?
Next article： Walensky prepares to leave CDC — and Congress — behind

focus

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Gene therapy has helped boys walk. Can scientists keep it that way?

GenetherapyhelpedConnerCurran(atright)walk,butasthedrugfades,hisfamilyissupportingscientificeffortst

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

ObesityexpertsJamyArd(left)andRobertLustigspeakatapanelduringthe2023STATBreakthroughSummit.SarahGonz

WSS

explore

explore

leisure time

focus

Obesity experts on risks of Wegovy, Ozempic weight loss drugs